AZ UROLOGY: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
AZ UROLOGY
Largest movements
- Cash +€59,425
up €59,425 (+12,977%), from €458 to €59,883
mainly Net result for the year (+€93,307) and Tax, wage and social debts (+€4,633)
- Deferred charges and accrued income +€34,952
up €34,952 (+334%), from €10,475 to €45,428
- Tangible fixed assets +€1,322
new in 2025: €1,322
- Profit (loss) carried forward +€93,307
up €93,307 (+2,409%), from €3,874 to €97,181
- Tax, wage and social debts +€4,633
up €4,633 (+430%), from €1,077 to €5,710
- Other debts -€3,145
down €3,145 (-92.1%), from €3,413 to €268
- Gross operating margin +€115,195
up €115,195 (+2,179%), from €5,286 to €120,481
- Taxes +€24,633
up €24,633 (+2,286%), from €1,077 to €25,710
- Financial charges +€1,285
up €1,285 (+10,282%), from €13 to €1,298
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €10,933 | €106,633 | +€95,700 | +875% |
| Fixed assets | 21/28 | - | €1,322 | +€1,322 | |
| Tangible fixed assets | 22/27 | - | €1,322 | +€1,322 | |
| Furniture and vehicles | 24 | - | €1,322 | +€1,322 | |
| Current assets | 29/58 | €10,933 | €105,311 | +€94,378 | +863% |
| Cash at bank and in hand | 54/58 | €458 | €59,883 | +€59,425 | +12,977% |
| Deferred charges and accrued income | 490/1 | €10,475 | €45,428 | +€34,952 | +334% |
| Total equity and liabilities | 10/49 | €10,933 | €106,633 | +€95,700 | +875% |
| Equity | 10/15 | €5,874 | €99,181 | +€93,307 | +1,588% |
| Contributions | 10/11 | €2,000 | €2,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | €3,874 | €97,181 | +€93,307 | +2,409% |
| Amounts payable | 17/49 | €5,059 | €7,452 | +€2,393 | +47.3% |
| Amounts payable within one year | 42/48 | €5,059 | €7,452 | +€2,393 | +47.3% |
| Trade debts | 44 | €569 | €1,474 | +€905 | +159% |
| Suppliers | 440/4 | €569 | €1,474 | +€905 | +159% |
| Taxes, remuneration and social security | 45 | €1,077 | €5,710 | +€4,633 | +430% |
| Taxes | 450/3 | €1,077 | €5,710 | +€4,633 | +430% |
| Other amounts payable | 47/48 | €3,413 | €268 | -€3,145 | -92.1% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | - | €101 | +€101 | |
| Other operating charges | 640/8 | €322 | €66 | -€256 | -79.6% |
| Gross operating margin | 9900 | €5,286 | €120,481 | +€115,195 | +2,179% |
| Operating profit (loss) | 9901 | €4,964 | €120,314 | +€115,350 | +2,324% |
| Financial income | 75/76B | - | €1 | +€1 | |
| Recurring financial income | 75 | - | €1 | +€1 | |
| Financial charges | 65/66B | €13 | €1,298 | +€1,285 | +10,282% |
| Recurring financial charges | 65 | €13 | €1,298 | +€1,285 | +10,282% |
| Profit (loss) for the period before taxes | 9903 | €4,952 | €119,017 | +€114,065 | +2,304% |
| Income taxes | 67/77 | €1,077 | €25,710 | +€24,633 | +2,286% |
| Profit (loss) for the period | 9904 | €3,874 | €93,307 | +€89,433 | +2,309% |
| Profit (loss) for the period to be appropriated | 9905 | €3,874 | €93,307 | +€89,433 | +2,309% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 26 October 2026 via checked.be.